KD Logo

Insider Buying: Boehler Adam, Privia Health Group Inc [PRVA] Director invested 364 shares

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Privia Health Group Inc shares valued at $6,006 were purchased by Boehler Adam on Jun 11 ’24. At $16.50 per share, Boehler Adam acquired 364 shares. The insider’s holdings grew to 5,773,522 shares worth approximately $112.18 million following the completion of this transaction.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Also, Boehler Adam purchased 5,306 shares, netting a total of over 87,549 in proceeds. Following the buying of shares at $16.50 each, the insider now holds 5,773,158 shares.

Before that, Boehler Adam had added 4,280 shares to its account. In a trade valued at $70,577, the Director bought Privia Health Group Inc shares for $16.49 each. Upon closing the transaction, the insider’s holdings increased to 4,280 shares, worth approximately $112.07 million.

As published in their initiating research note from Robert W. Baird on May 30, 2024, Privia Health Group Inc [PRVA] has been an Outperform and the price target has been revised to $23. Analysts at Citigroup started covering the stock with ‘”a Buy”‘ outlook in a report released in late April. As of March 06, 2024, Barclays has initiated its “an Equal weight” rating for PRVA.

Analyzing PRVA Stock Performance

During the last five days, there has been a surge of approximately 0.78%. Over the course of the year, Privia Health Group Inc shares have dropped approximately -15.63%. Shares of the company reached a 52-week high of $24.05 on 01/02/24 and a 52-week low of $15.92 on 05/21/24. A 50-day SMA is recorded $18.55, while a 200-day SMA reached $19.93. Nevertheless, trading volume fell to 0.52 million shares from 0.8 million shares the previous day.

Support And Resistance Levels for Privia Health Group Inc (PRVA)

According to the 24-hour chart, there is a support level at 19.19, which, if violated, would cause prices to drop to 18.96. In the upper region, resistance lies at 19.84. The next price resistance is at 20.26. RSI (Relative Strength Index) is 50.71 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.32, which suggests the price will decrease in the coming days. Percent R is at 45.21%, indicating low price movement. Stochastics%K at holding indicates that the stock is to be held.

Most Popular